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OBJECTIVES This study sought to evaluate the clinical results of a percutaneous approach to mitral valve
repair for mitral regurgitation (MR).
BACKGROUND A surgical technique approximating the middle scallops of the mitral leaflets to create a
double orifice with improved leaflet coaptation was introduced in the early 1990s. Recently,
a percutaneous method to create the same type of repair was developed. A trans-septal
approach was used to deliver a clip device that grasps the mitral leaflet edges to create the
double orifice.
METHODS General anesthesia, fluoroscopy, and echocardiographic guidance are used. A 24-F guide is
positioned in the left atrium. The clip is centered over the mitral orifice, passed into the left
ventricle, and pulled back to grasp the mitral leaflets. After verification that MR is reduced,
the clip is released.
RESULTS Twenty-seven patients had six-month follow-up. Clips were implanted in 24 patients. There
were no procedural complications and four 30-day major adverse events: partial clip
detachment in three patients, who underwent elective valve surgery, and one patient with
post-procedure stroke that resolved at one month. Three additional patients had surgery for
unresolved MR, leaving 18 patients free from surgery. In 13 of 14 patients with reduction of
MR to 2 after one month, the reduction was maintained at six months.
CONCLUSIONS Percutaneous edge-to-edge mitral valve repair can be performed safely and a reduction in MR
can be achieved in a significant proportion of patients to six months. Patients who required
subsequent surgery had elective mitral valve repair or intended replacement. (J Am Coll



















ritral valve repair is the preferred surgical approach for
reatment of severe mitral regurgitation (MR). Surgical
utcomes show higher risk for replacement compared with
epair (1). A variety of surgical approaches for mitral valve
See page 2141
epair are in wide use, including annuloplasty, leaflet repair,
nd chordal reconstruction. Beginning in 1991, a surgical
echnique involving approximation of the middle scallops of
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ccepted July 19, 2005.he anterior and posterior mitral leaflets was described
2–5). This approach, initially used for anterior leaflet
rolapse, results in a double-orifice mitral valve and re-
stablishes leaflet coaptation. Creation of a double-orifice
itral valve has subsequently been used as a surgical mitral
alve repair technique for patients suffering from MR
aused by leaflet prolapse, secondary regurgitation attribut-
ble to ischemia, and left ventricular dilatation with heart
ailure (6). Recently a percutaneous method for creating the
ame type of double-orifice repair has been developed (7,8).
he trans-septal approach is used to deliver a clip device
hat can grasp the central mitral leaflet edges to create a
ouble orifice. After extensive testing in animals showed
ersistence of a double orifice for more than six months, a
.S. Food and Drug Administration Investigational Device
xemption-approved phase I safety and feasibility trial
EVEREST: Endovascular Valve Edge-to-Edge Repair
tudy) was initiated (7,8). The short-term and six-month
esults of this trial in 27 patients with moderate-to-severe or
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itral valve repair device. The MitraClip system uses a
lip with a tri-axial catheter system (Evalve Inc., Menlo
ark, California). The tip of the outer guide catheter is
elivered to the left atrium using a standard trans-septal
pproach over a guidewire and tapered dilator. The guide
atheter is 24-F proximally, and tapers to 22-F at the point
here it crosses the atrial septum. A steering knob on the
roximal end of the guide catheter allows flexion and lateral
ovement of the distal tip.
A clip delivery system, with a clip attached to its distal
nd, is passed through the guide catheter. This system is
teerable using a two-knob coaxial system that permits
edial-lateral and anterior-posterior steering. The clip de-
ivery system is advanced through the guide catheter into the
eft atrium and is positioned so that the clip is orthogonal to
he three planes of the mitral valve and over the origin of the
egurgitant jet.
The clip is a polyester-covered mechanical device with
wo arms that are opened and closed by control mechanisms
n the clip delivery system (Fig. 1). The two arms have an
pened span of approximately 2 cm when opened in the
rasping position. The width of the clip is 4 mm. On the
nner portion of the clip is a U-shaped “gripper” that
atches up to each arm and helps to stabilize the leaflets
rom the atrial aspect as they are captured during closure of
he clip arms (Fig. 2). Leaflet tissue is secured between the
losed arms and each side of the gripper, and the clip is then
losed and locked to effect and maintain coaptation of the
wo leaflets.
rocedure technique. The procedure is performed under
eneral anesthesia using fluoroscopy and both transesopha-
igure 1. Photograph of the clip attached to the delivery system. The clip
s covered with polyester fabric. The two arms are opened and closed by
Abbreviations and Acronyms
MAE  major adverse event
MR  mitral regurgitationi
ontrol mechanisms on the clip delivery system. The two arms have an
pened span of approximately 2 cm and a width of 4 mm.eal and transthoracic echocardiographic guidance. After
rans-septal puncture using standard techniques, heparin is
dministered to achieve an activated clotting time of 250 s
r more. A 0.035-inch guidewire is passed into the left
trium, and the trans-septal apparatus is exchanged for the
uide catheter. The guide is positioned in the mid left
trium, de-aired, and flushed. The clip delivery system is
ntroduced into the guide catheter, and the clip is advanced
nto the left atrial chamber. Using echocardiographic and
uoroscopic guidance, the clip is moved in small iterations
ntil it is centered over the mitral orifice. The arms of the
lip are opened and oriented perpendicular to the long axis
f the leaflet edges, and then the clip is advanced into the
eft ventricle just below the mitral leaflet edges. The clip is
losed to 120° and pulled back until the mitral leaflets are
aptured in the arms of the clip. The gripper is then lowered
nto the atrial aspect of the leaflets. The clip is partially
losed. At this point, achievement of a double-orifice mitral
alve, leaflet insertion into the closed clip arms, and the
egree of MR can be assessed using Doppler echocardiog-
aphy. Next, the clip is closed incrementally under real-time
chocardiography to optimize the reduction of MR. For the
rst 10 patients enrolled in the trial, only one clip could be
sed. Beginning with the 11th patient, a protocol change
llowed a second clip to be placed if only partial improve-
ent was achieved with a single clip. If necessary, the clip
an be opened, the mitral leaflets released, and the clip
epositioned. In the event that the clip must be withdrawn
ack into the left atrium, the clip arms are everted so that
hey may be retracted through the mitral apparatus into the
eft atrium without entangling the chordae tendinea. After
dequate reduction of MR is achieved, the clip is released
rom the clip delivery system and the delivery system and
uide catheter are withdrawn. Repeat hemodynamic, angio-
raphic, and echocardiographic assessments are performed.
fter a clip was placed, patients were treated with aspirin
25 mg daily for 6 months and clopidogrel 75 mg daily for
0 days.
atient selection. Patients were selected for therapy if they
et basic criteria for intervention from the American
ollege of Cardiology/American Heart Association Joint
ask Force recommendations regarding therapy for valvular
eart disease (9). Patients with moderate-to-severe or severe
R who were symptomatic or asymptomatic patients with
oderate-to-severe or severe MR with compromised left
entricular function (left ventricular ejection fraction 60%
r left ventricular end-systolic dimension 45 mm) were
elected (Table 1). A screening echocardiogram was re-
iewed by a core laboratory (University of California at San
rancisco). Mitral regurgitation was graded according to the
riteria of the American Society of Echocardiography (10).
n the basis of the screening echocardiogram, a minimum
f three of six criteria for moderate to severe (3) or severe
4) MR were required for entry; at least one of the three
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Percutaneous Mitral Repair December 6, 2005:2134–40rigin from within the central two-thirds of the line of
eaflet coaptation. Specific anatomic measurements were
ade according to the protocol.
All patients were candidates for mitral valve surgery in the
vent that it was required for managing potential compli-
ations. Patients were excluded if they had recent myocar-
ial infarction within 14 days of the intended percutaneous
itral repair, if any interventional or surgical procedure was
erformed within 30 days of the index procedure, if they
ad prior median sternotomy, or if the etiology of MR was
heumatic or infectious. Left ventricular dysfunction with an
jection fraction 30%, left ventricular end-systolic dimen-
ion 55 mm, and mitral valve orifice area 4 cm2 were
lso exclusion criteria. The protocol was approved by the
nstitutional review boards of the participating centers
Appendix).
tudy end points. The primary end point of the study was
cute safety at 30 days defined as freedom from death,
yocardial infarction, cardiac tamponade, cardiac surgery
or failed clip, clip detachment, stroke, or septicemia. The
nd point was met if the major adverse event (MAE) rate
igure 2. Schematic drawing of the components of the clip. On the inner
o stabilize the leaflets from the atrial aspect as they are captured during clo
ide of the gripper, and the clip is then closed and locked to effect and m
able 1. Criteria for Moderate-Severe or Severe MR
itral regurgitant severity of moderate-to-severe or severe grade as
defined by a minimum of three of the following criteria, one of
which must be quantitative (i.e., 4, 5, or 6):
1. Color flow jet may be central and large (6 cm2 or 30% of left
atrial area) or smaller if eccentric, encircling the left atrium
2. Pulmonary vein flow may show systolic blunting or systolic flow
reversal
3. Vena contracta width 0.3 cm measured in the parasternal long-
axis view
4. Regurgitant volume of 45 ml/beat
5. Regurgitant fraction 40%m6. Regurgitant orifice area 0.30 cm
2as 34.4%, which was based on the event rate in the
ociety of Thoracic Surgeons cardiac surgical database of
7.0% for mitral valve surgery, with a large margin of error
or a relatively small sample size (11).
Secondary safety end points included in-hospital major
ascular complications, 30-day and 6-month major bleed-
ng, endocarditis, clip thrombosis, hemolysis, and mitral
alve injury. At the six-month time point, cardiac surgery
or a failed clip or device was also a secondary safety end
oint.
Echocardiograms were performed according to a pre-
pecified protocol at baseline, pre-discharge, and at one
nd six months (Fig. 3). The efficacy goal was defined as
R severity of 2 after clip placement. On the
aseline and follow-up (pre-discharge, 30-day, 6-month)
chocardiograms, MR was graded based on four of the six
riteria used at screening. The vena contracta width and
he regurgitant orifice area have not been validated for the
ouble-orifice valve, and thus were eliminated from this
nalysis. A four-point score was based on the average of
our variables graded on a scale of 1 to 4. An overall
expert” grade was also assigned based on integrated core
aboratory analysis that considered regurgitant volume,
egurgitant fraction, color jet penetration, pulmonary
enous flow pattern, and continuous-wave Doppler char-
cteristics of the regurgitant jet, pulmonary artery pres-
ure, and left atrial size using a previously validated
pproach (12). To evaluate for the potential development
f mitral valve stenosis, mitral valve area was measured by
lanimetry, pressure half-time, and mean gradient. After
he procedure, each of the two orifices underwent
lanimetry at the level of the clip and was summed for the
n of the clip is a U-shaped gripper that matches up to each arm and helps
f the clip arms. Leaflet tissue is secured between the closed arms and each
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atient characteristics. Clinical features of 27 patients
mean age, 69  12 years) who underwent a percutaneous
itral repair procedure are shown in Table 2: 59% were
en, 59% had a history of congestive heart failure, 41% had
trial fibrillation, and 44% were New York Heart Associa-
ion functional class III or IV. The etiology of MR is shown
n Table 3: 93% of patients had degenerative MR and 7% of
atients had ischemic MR. Six-month follow-up was avail-
ble for the 24 patients who received clips.
Figure 3. Flow chart showing ov
able 2. Clinical Features
% n
ge (mean), yrs 68.6  12.5 27
ale gender 59% 16
iabetes mellitus 15% 4
ypertension 63% 17
OPD 18% 5
istory of CHF 59% 16
trial fibrillation 41% 11
YHA functional class III/IV 44% 12HF  congestive heart failure; COPD  chronic obstructive pulmonary disease;
YHA  New York Heart Association.
Irocedure and hospital results. Figure 3 shows the overall
rocedure results for all 27 patients. A clip was successfully
mplanted in 24 of 27 patients. There was one clip im-
lanted in 20 patients, and 4 patients were treated with two
lips. The protocol was amended after the first 10 patients
o allow placement of two clips if needed. A clip was not
mplanted in three of the first seven patients treated for
nadequate reduction of the degree of MR. The clip and
elivery system were uneventfully removed at the time of the
ttempted percutaneous repair from all three of these
atients without any MAE. All three underwent their
re-procedure indicated elective surgery, with valve repair in
wo and intended valve replacement in one. One of these
atients was found to have a cleft between P1 and P2 at
urgery. The use of two clips was not an option when these
atients were treated. In a fourth patient, the clip was placed
results for the 27 study patients.
able 3. Mitral Regurgitation Etiology
egenerative 25 (93%)
P2 prolapse/flail 14 (56%)
Bi-leaflet prolapse/flail 10 (40%)
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Percutaneous Mitral Repair December 6, 2005:2134–40n the leaflets and control of MR was not adequate. It was not
ossible to re-open the clip. It was thus deployed, and the
atient went for elective uneventful surgical mitral valve repair.
Nine procedures were done at one site, eight procedures
t one site, three at two sites, and two each at two sites. The
verage device time defined as the time from guide insertion
ntil clip delivery system removal diminished with experi-
nce. For all 27 procedures, the mean device time was 204
116 min. First procedures (six patients) had a mean
evice time of 227 min, second procedures (six patients) had
mean device time of 363 min (one of these was the first
ime two clips were placed, with a procedure time of 530
in), and third procedures (four patients) had mean device
ime of 196 min. For procedures in which one clip was
laced, the mean device time was 168  73 min. Two clip
ases had a mean device time of 396  145 min. Cases in
hich no clip was ultimately implanted had a mean device
ime of 198  19 min. Because clip placement was guided
rimarily by echocardiography, fluoroscopy was not used
ontinuously during the procedure.
In-hospital outcomes are shown in Table 4. The length-
f-stay time includes three patients who went on to have
urgery during the initial hospitalization.
rimary end point. The primary end point results are
hown in Table 5: 85% of patients were free from 30-day
AEs (95% confidence limits, 71% to 98%). There were no
eaths. One patient had a non-embolic stroke associated
ith post-procedure hypotension, defined as a persistent
eurologic deficit of more than 72 h. The symptoms had
esolved by the one-month follow-up evaluation. No patient
nderwent emergency cardiac surgery for a failed clip. Clip
etachment from one of the two mitral leaflets occurred in
able 4. In-Hospital Outcomes
CU/CCU time (h) 48 (0–417)
echanical ventilation 24 h 0
ew onset of AF 0
lood product use 1
ccess site complications requiring surgery 0
enal failure or dialysis 0
ost-procedural hospital stay (days)* 2.5 (0.75–16)
ischarged home (without home health care) 27
2.5 days includes 3 patients who remained in the hospital for elective surgery. For 24
atients who did not undergo surgery during the same admission, post-procedural
ospital stay was 1.7 days.
AF  atrial fibrillation; ICU/CCU  intensive care unit/cardiac care unit.
able 5. Primary End Point: 30-Day Major Adverse Events
reedom from 30-day MAE 85%
eath 0
ermanent stroke 1
ardiac surgery for failed clip 0







fAE  major adverse events.hree patients. One of these was detected on the 24-h
ollow-up echocardiogram and the other two at the 30-day
chocardiogram. Clip embolization did not occur in any
atient. There were no occurrences of myocardial infarction,
ardiac tamponade, or septicemia. As previously described,
n one patient after the clip was initially placed, it was
etermined that MR reduction was not adequate. It was not
ossible to open the clip, and it was thus deployed. The
atient was scheduled for and underwent uneventful mitral
alve repair the following day.
Twenty-two of the 27 patients (82%) were discharged
rom the hospital with a clip in place (Fig. 4). Four patients
ith baseline MR severity of 4 were improved to 3 at
ischarge but did not have their MR severity reduced to 2
r less in the short term per core laboratory assessment. Two
atients experienced a recurrence of MR at 30 days, and two
atients had partial clip detachment. Thus, at the one-
onth time point, 14 patients had MR 2, and 13 of 14
aintained this improvement at six months. The mitral
alve area by planimetry was 6.4  1.6 cm (2) at baseline
nd 3.4  1.7 cm (2) at six months, and by pressure
alf-time was 4.4  0.80 cm (2) at baseline and 2.9  0.83
m (2) after six months.
Six patients with MR after percutaneous repair under-
ent surgery (13). The time interval between percutaneous
lip deployment and surgical revision ranged from 1 to 133
ays. During open surgical revision, the clips were unevent-
ully removed in all five cases in which the intention was to
epair the valve with no limitation in surgical options. One
f these patients had been treated with two clips. In the
emaining case of surgical revision, there was no attempt to
emove the clip from the valve leaflets during intended
itral valve replacement.
Among patients having six-month follow-up transtho-
acic echocardiograms, color Doppler evidence of atrial
eptal shunting was present in four, absent in seven, and
ndeterminate in eight patients.
igure 4. Short axis transthoracic echocardiogram showing a double-
rifice mitral valve. The clip can be seen plainly in the center of the
ouble orifice (arrow). The image was obtained from the first patient
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December 6, 2005:2134–40 Percutaneous Mitral RepairAmong patients discharged from the hospital with a clip
n place, the overall freedom from valve surgery at six
onths was 18 of 22 (82%).
ISCUSSION
fficacy. This initial human clinical experience shows that
ercutaneous edge-to-edge mitral valve repair can be per-
ormed safely, that the degree of MR can be reduced
ignificantly, and that the reduction in MR can be sustained
t six months.
The clip is deliverable using the trans-septal approach.
oaptation of the anterior and posterior leaflets produces a
ouble-orifice mitral valve and can reduce MR. Combined
uoroscopic and echocardiographic guidance is adequate to
rient the device properly in multiple planes so that it can be
ositioned over the center of the mitral valve orifice and the
rigin of the MR jet. An echo short-axis view, either
ransthoracic or transesophageal, is needed to orient the clip
erpendicular to the line of leaflet coaptation before grasp-
ng. The grasping and capturing mechanisms of the clip
ere both used successfully. It is possible to grasp and safely
elease mitral leaflets repeatedly and to reposition the device
o achieve optimal control of MR. The gripping mechanism
esults in stability of the clip on the mitral leaflets both
efore and after detachment in most patients. It has been
stablished that a tissue bridge forms across the clip in
nimal models (7). This healing response reproduces the
xisting surgical approach and has not resulted in significant
nflow obstruction in any patient. The surgical approach for
dge-to-edge repair has been in use for over a decade, with
xcellent results in many patients.
Reductions in MR were achieved in most of our patients.
n some, the acute result was almost complete resolution of
egurgitation, whereas in others it has resulted in a signifi-
ant improvement in MR: 64% of patients discharged with
clip had MR 2 after one month, which increased to
2% when each investigator’s first and second procedures
ere excluded. Although the sample size is small, this
nding may support the presence of a learning curve.
mportantly, 93% of patients with MR 2 at one month
ad a stable result after six months.
The mean device time from guide catheter insertion until
lip delivery system withdrawal ranged from over 200 min
or first procedures to a minimum of 70 min in a ninth
rocedure. One case that involved placement of two clips
asted over 500 min. Despite the duration of the procedures,
anipulation of this relatively large system of catheters in
he left atrium, mitral orifice, and left ventricle was tolerated
emarkably well. Patients were hemodynamically stable
hroughout the procedure in all cases. No patient required
notropic support for completion of the procedure, and none
eveloped atrial fibrillation, ventricular tachycardia, or acute
r delayed pericardial tamponade. The hemodynamic sta-
ility observed during this procedure is in marked contrast
o the instability of patients undergoing other percutaneous iatheter valve procedures such as balloon aortic and balloon
itral valvuloplasty or percutaneous aortic valve replace-
ent. The hemodynamic stability of these patients allows
he interventional team to remain focused on steering the
lip to the optimal location over the mitral orifice, grasping
he leaflets, and ensuring a good result rather than being
reoccupied with the management of an unstable patient.
The ability to grasp and remove the clip both during the
nitial procedure and also during subsequent surgery is an
mportant aspect of the technology. In three patients,
ultiple grasps were made without adequate control of MR
nd the device was removed. This did not preclude conven-
ional valve surgical therapy including valve repair in any of
hese patients. The reversibility of the grasping mechanism
f the clip is also critically important. It has been possible to
rasp leaflets and assess the degree of improvement in MR,
nd then reposition the clip if necessary to optimize control
f MR. The clip has also been removed during subsequent
pen surgical procedures. Six patients with MR after per-
utaneous repair have undergone re-intervention with a
ime interval between clip deployment and surgery from 1 to
33 days (13). During surgery, the clips were uneventfully
emoved in all five cases in which the intention was to repair
he valve with no limitation in surgical options, including
ne patient treated with two clips.
afety. The safety of the device has been clearly shown.
he large caliber of the trans-septal puncture has not caused
ny specific problems. Trans-septal access using devices of
his size has been accomplished previously without long-
erm sequelae with double-balloon mitral valvuloplasty, and
ore recently with trans-septally delivered percutaneous
ypass procedures.
The 24-F femoral venous puncture has been manageable
n all of these patients without any special techniques.
anual compression or pneumatic compression using the
emoStop device has been used without any late bleeding.
trial septal shunting from the trans-septal puncture has
ot been clinically important in any patients. Most seem to
e healed by six months.
Partial clip detachment from one leaflet without em-
olization occurred in three patients. One of these was
etected at the 24-h post-procedure echocardiogram, and
he other two were noted at the planned protocol-driven
ne-month echocardiographic examination. None of these
atients had a change in symptoms or a clinical event related
o clip detachment from one leaflet. Careful retrospective
eview of the intraprocedural echocardiograms in these three
atients suggests that the angle between the open clip arms
nd the long axis of the line of mitral coaptation was not
erpendicular at the time the leaflets were grasped. Depend-
ng on the extent of misalignment, this may result in less
eaflet capture on one or both sides of the two clip arms.
ased on this experience, it is apparent that careful assess-
ent to confirm a perpendicular orientation of the open clip
rms to the long axis of the mitral leaflet line of coaptation
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Percutaneous Mitral Repair December 6, 2005:2134–40lip. In addition, proper leaflet insertion into the closed clip
rms should be systematically assessed before final clip
eployment.
tudy limitations. The major limitation of this technique
as been the inability to completely obliterate MR in all
atients. This article characterizes early experience with a
rst-in-class device therapy for MR. As seen in Figure 3, 14
f 27 patients had MR reduced to 2 at six months. In
our patients, the use of two clips was needed to achieve an
dequate reduction in MR. It is clear that the geometry of
he regurgitant orifice and the origin of the MR jet are
ighly variable in position and dimension. The need to
ncrease the width of the apposed segments of coaptation
ith two-clip devices can be assessed after a single clip has
een placed, if the residual jet origin can be clearly seen
djacent to the deployed clip. Similar to surgical edge-to-
dge repair, it is possible that creation of a triple-orifice
alve will be effective in some patients as well (14). The
xperience with functional MR in this trial is limited,
lthough initially positive. Additional experience will be
equired to determine an optimal strategy for the use of
ultiple clips. The potential to create mitral stenosis must
lso carefully be evaluated as multiple clips are used. It is
otable that mitral stenosis was not created in any of these
atients, including the four who received two clips. Expe-
ience is limited to 25 patients with degenerative MR and
4 patients with flail leaflets, so the specific features of this
tiology that may limit the utility of this first-generation
evice will also require further experience to define. The
xperience with functional MR in this trial is limited,
lthough initially positive. The primary reason that experi-
nce with functional patients is limited is the protocol
andated exclusion of patients with previous mediastinal
urgery. Longer-term follow-up will be required to deter-
ine clinical value in different patient populations.
The surgical approach to MR may involve a combination
f edge-to-edge repair and annuloplasty. Satisfactory four-
ear freedom from reoperation rates have been described
mong patients having edge-to-edge repair without annu-
oplasty, as well as in patients in whom edge-to-edge repair
as used to supplement annuloplasty (15). Some cases of
R will require more than isolated edge-to-edge repair for
dequate therapy. This strategy may be modified in patients
ho are poor candidates for surgery, in whom no mechan-
cal alternatives for mitral repair are available, and the use of
clip repair without annuloplasty may be the patient’s only
easonable alternative.
ONCLUSIONS
he safety and feasibility of the technique of percutaneous
dge-to-edge mitral valve repair has been shown in this phase
study. Based on an existing surgical approach, the use of the
lip seems to accomplish a similar anatomic mitral leaflet
epair. Additional follow-up will help clarify the durability and
fficacy of this technique. The potential to treat patients who ore otherwise surgical candidates, some who may be too
igh-risk for conventional surgical approaches, and possibly
hose who are at an earlier point in the natural history of MR,
ill also require further definition. The risk-benefit profile of
his technique in comparison with surgery will be evaluated in
n ongoing phase II randomized trial.
eprint requests and correspondence: Dr. Ted Feldman, Evan-
ton Hospital, Cardiology Division-Burch 300, 2650 Ridge Ave-
ue, Evanston, Illinois 60201. E-mail: tfeldman@enh.org.
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